Virtual Medicinal Product (VMP) - Fluoxetine 20mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Fluoxetine 20mg/5ml oral suspension | Start Date 13-03-2023 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5.0
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- N06AB03
- BNF Codes
-
- BNF code 04030300
| Code | Start Date | End Date |
|---|---|---|
| 41535111000001102 | 13-03-2023 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Fluoxetine hydrochloride | Based on Base Substance | Fluoxetine | 4 mg | 1 ml |
Name
Fluoxetine hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Fluoxetine
Strength and UOM (Nmr)
4.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMFluoxetine
-
VMP(Current) Fluoxetine 20mg/5ml oral suspension
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml |